Future directions in the prevention of prostate cancer

被引：0
作者：
Ian M. Thompson
April B. Cabang
Michael J. Wargovich
机构：
[1] Cancer Therapy and Research Center,
[2] University of Texas Health Science Center at San Antonio,undefined
来源：
Nature Reviews Clinical Oncology | 2014年 / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Chemoprevention has been increasingly explored to mitigate the global burden of prostate cancer and the overtreatment of indolent disease that has arisen in the prostate-specific antigen (PSA) screening eraPreclinical and epidemiological evidence suggested that selenium and α-tocopherol (vitamin E) might reduce the risk of prostate cancerA large trial found vitamin E to significantly increase the risk of prostate cancer and selenium to have no effect on riskThe strongest evidence supports the use of 5α-reductase inhibitors for prostate cancer prevention, with recent data showing that the risk reduction with these agents is 30%
引用
收藏
页码：49 / 60
页数：11
相关论文
共 283 条
[101]  
Wang J(2012)Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study Br. J. Cancer 107 207-837
[102]  
Eltoum IE(2012)Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung Am. J. Epidemiol. 176 156-1098
[103]  
Lamartiniere CA(2013)Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study Eur. J. Cancer 49 938-14
[104]  
Nakamura H(2012)Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial Lancet 379 1591-762
[105]  
Van Poppel H(2010)Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level Cancer Prev. Res. (Phila.) 3 885-39
[106]  
Tombal B(2010)Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials Pharmacoepidemiol. Drug Saf. 19 752-2010
[107]  
McCormick DL(2010)A novel sulindac derivative lacking cyclooxygenase-inhibitory activities suppresses carcinogenesis in the transgenic adenocarcinoma of mouse prostate model Cancer Prev. Res. (Phila.) 3 114-1681
[108]  
Johnson WD(2009)Statin and NSAID use and prostate cancer risk Arch. Biochem. Biophys. 486 95-16
[109]  
Bosland MC(2010)Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence Biofactors 36 360-8
[110]  
Lubet RA(2012)Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms Oncologist 17 830-1176
6789101112131415